scholarly journals Purification of A1 adenosine receptor–G-protein complexes: effects of receptor down-regulation and phosphorylation on coupling

1999 ◽  
Vol 338 (3) ◽  
pp. 729-736 ◽  
Author(s):  
Zhenhai GAO ◽  
Anna S. ROBEVA ◽  
Joel LINDEN
Keyword(s):  
G Protein ◽  
Protein Complexes ◽  
Regulatory Protein ◽  
Chinese Hamster ◽  
Down Regulation ◽  
Intact Cells ◽  
Low Level ◽  
Receptor Purification ◽  
Guanine Nucleotide Binding ◽  
The Stability

We examined the effects of exposing A1 adenosine receptors (A1ARs) to an agonist on the stability and phosphorylation state of receptor–guanine nucleotide-binding regulatory protein (R–G-protein) complexes. Non-denatured recombinant human A1ARs extended on the N-terminus with hexahistidine (His6) and the FLAG (Asp-Tyr-Lys-Asp-Asp-Asp-Asp-Lys) epitope (H/F) were purified to near homogeneity from stably transfected Chinese-hamster ovary (CHO)-K1 cells. Purified receptors have pharmacological properties similar to receptors in membranes. G-proteins were co-purified with 15±2% of H/F-A1AR unless receptor–G-protein (R–G) complexes were uncoupled by pre-treating cell membranes with GTP. By silver staining, purified A1AR–G-protein complexes contain receptors, G-protein α and β subunits and an unidentified 97 kDa protein. Pretreating intact cells with N6-cyclopentyladenosine (CPA) for 24 h decreased both the total number of receptors measured in membranes and the number of purified A1ARs by about 50%. In contrast, pretreating cells with CPA decreased the number of R–G complexes measured in membranes (54±6%) significantly less than it decreased the number of purified R–G complexes (78±3%) as detected by 125I-N6-(4-aminobenzyl)adenosine binding or by Western blotting Giα2. The effect of CPA to decrease the fraction of receptors purified as R–G complexes was not associated with any change in low-level A1AR phosphorylation (found on serine), or low-level phosphorylation of G-protein α or β subunits or the 97 kDa protein. These experiments reveal a novel aspect of agonist-induced down-regulation, namely a diminished stability of receptor–G-protein complexes that is manifested as uncoupling during receptor purification.

Agonist-induced translocation of Gq/11α immunoreactivity directly from plasma membrane in MDCK cells

1999 ◽  
Vol 276 (4) ◽  
pp. F528-F534
Author(s):  
John M. Arthur ◽  
Georgiann P. Collinsworth ◽  
Thomas W. Gettys ◽  
John R. Raymond
Keyword(s):  
Plasma Membrane ◽  
G Protein ◽  
Plasma Membranes ◽  
Protein Translocation ◽  
Mdck Cells ◽  
Regulatory Protein ◽  
Intact Cells ◽  
Intracellular Location ◽  
Signaling Specificity ◽  
Guanine Nucleotide Binding

Both Gsα and Gqα are palmitoylated and both can move from a crude membrane fraction to a soluble fraction in response to stimulation with agonists. This response may be mediated through depalmitoylation. Previous studies have not demonstrated that endogenous guanine nucleotide-binding regulatory protein (G protein) α-subunits are released directly from the plasma membrane. We have examined the effect of agonist stimulation on the location of Gq/11α immunoreactivity in Madin-Darby canine kidney (MDCK) cells. Bradykinin (BK; 0.1 μM) caused Gq/11α, but not Giα, to rapidly translocate from purified plasma membranes to the supernatant. AlF and GTP also caused translocation of Gq/11α immunoreactivity from purified plasma membranes. BK caused translocation of Gq/11α immunoreactivity in intact cells from the basal and lateral plasma membranes to an intracellular compartment as assessed by confocal microscopy. Thus Gq/11α is released directly from the plasma membrane to an intracellular location in response to activation by an agonist and direct activation of G proteins. G protein translocation may be a mechanism for desensitization or for signaling specificity.

scholarly journals Desensitization of tumour Leydig cells by lutropin: evidence for uncoupling of the lutropin receptor from the guanine nucleotide-binding protein

1982 ◽  
Vol 202 (3) ◽  
pp. 739-745 ◽  
Author(s):  
Clive J. Dix ◽  
Matthias Schumacher ◽  
Brian A. Cooke
Keyword(s):  
Cyclic Amp ◽  
Plasma Membranes ◽  
Regulatory Protein ◽  
Linear Increase ◽  
Guanine Nucleotide ◽  
Production Rates ◽  
Guanine Nucleotide Binding Protein ◽  
Intact Cells ◽  
Guanine Nucleotide Binding ◽  
Guanine Nucleotide Regulatory Protein

Purified rat Leydig tumour cells were pretreated with lutropin and the effect on the subsequent response to lutropin was determined. Maximal cyclic AMP production was achieved with the same concentration of lutropin in control and lutropin-pretreated cells; however, the maximum stimulated level in pretreated cells was only 30% of controls. The sensitivity to lutropin was decreased in lutropin-pretreated cells [ED50 (dose that produces a response that is 50% of the maximum response) 60±5.7ng/ml and 8±1.8ng/ml (mean±s.d., n=3) for controls], as was the rate of maximal cyclic AMP production (0.58, compared with 1.89pmol/106 cells per min for controls). However, cholera-toxin-stimulated cyclic AMP production was not decreased by lutropin pretreatment, and a potentiation was seen at all time points studied (up to 6h). Pre-incubation with lutropin caused a decrease in specific 125I-labelled human choriogonadotropin binding; however, this decrease was abolished if the cells were washed under acidic conditions (pH3.0 for 2min at 4°C), indicating that occupation but not loss of the lutropin receptors had taken place. The effect of pretreating the cells with lutropin on adenylate cyclase activity in purified plasma membranes was also investigated. In plasma membranes from control cells both guanosine 5′-[β,γ-imido]triphosphate [p(NH)ppG] plus lutropin and NaF plus lutropin caused a 50–60-fold linear increase in cyclic AMP production over 40min compared with 15-fold with p(NH)ppG and 6-fold with lutropin alone. In plasma membranes isolated from lutropin-treated cells the NaF-plus-lutropin- and the p(NH)ppG-stimulated cyclic AMP production rates were unchanged but no effect of lutropin could be demonstrated with or without added p(NH)ppG. In contrast the plasma membranes from dibutyryl cyclic AMP-treated cells had similar cyclic AMP production rates to control cells with all stimulants studied. The present evidence obtained from studies both with intact cells and with isolated plasma membranes indicates that the initial lutropin-induced desensitization of the rat Leydig tumour cell is due to a lesion in the hormone-receptor coupling to the guanine nucleotide regulatory protein. This process is apparently not mediated by cyclic AMP.

scholarly journals Comprehensive analysis of heterotrimeric G-protein complex diversity and their interactions with GPCRs in solution

2015 ◽  
Vol 112 (11) ◽  
pp. E1181-E1190 ◽  
Author(s):  
Matthias Hillenbrand ◽  
Christian Schori ◽  
Jendrik Schöppe ◽  
Andreas Plückthun
Keyword(s):  
G Protein ◽  
G Proteins ◽  
Conformational Changes ◽  
Protein Complex ◽  
Protein Complexes ◽  
Heterotrimeric G Proteins ◽  
Agonist Binding ◽  
Transient Nature ◽  
The Stability ◽  
Neurotensin Receptor 1

Agonist binding to G-protein–coupled receptors (GPCRs) triggers signal transduction cascades involving heterotrimeric G proteins as key players. A major obstacle for drug design is the limited knowledge of conformational changes upon agonist binding, the details of interaction with the different G proteins, and the transmission to movements within the G protein. Although a variety of different GPCR/G protein complex structures would be needed, the transient nature of this complex and the intrinsic instability against dissociation make this endeavor very challenging. We have previously evolved GPCR mutants that display higher stability and retain their interaction with G proteins. We aimed at finding all G-protein combinations that preferentially interact with neurotensin receptor 1 (NTR1) and our stabilized mutants. We first systematically analyzed by coimmunoprecipitation the capability of 120 different G-protein combinations consisting of αi1or αsLand all possible βγ-dimers to form a heterotrimeric complex. This analysis revealed a surprisingly unrestricted ability of the G-protein subunits to form heterotrimeric complexes, including βγ-dimers previously thought to be nonexistent, except for combinations containing β5. A second screen on coupling preference of all G-protein heterotrimers to NTR1 wild type and a stabilized mutant indicated a preference for those Gαi1βγ combinations containing γ1and γ11. Heterotrimeric G proteins, including combinations believed to be nonexistent, were purified, and complexes with the GPCR were prepared. Our results shed new light on the combinatorial diversity of G proteins and their coupling to GPCRs and open new approaches to improve the stability of GPCR/G-protein complexes.

scholarly journals Hormonal regulation of Gi2 α-subunit phosphorylation in intact hepatocytes

1990 ◽  
Vol 268 (2) ◽  
pp. 449-457 ◽  
Author(s):  
M Bushfield ◽  
G J Murphy ◽  
B E Lavan ◽  
P J Parker ◽  
V J Hruby ◽  
...  
Keyword(s):  
Angiotensin Ii ◽  
Protein Kinase ◽  
G Protein ◽  
Hormonal Regulation ◽  
Dose Effect ◽  
Alpha Subunit ◽  
Intact Cells ◽  
Α Subunit ◽  
Guanine Nucleotide Binding ◽  
Dose Dependent

Hepatocytes contain the Gi2 and Gi3 forms of the ‘Gi-family’ of guanine-nucleotide-binding proteins (G-proteins), but not Gi1. The anti-peptide antisera AS7 and I3B were shown to immunoprecipitate Gi2 and Gi3 selectively, and the antiserum CS1 immunoprecipitated the stimulatory G-protein Gs. Treatment of intact, 32P-labelled hepatocytes with one of glucagon, TH-glucagon ([1-N-alpha-trinitrophenylhistidine, 12-homoarginine]glucagon), Arg-vasopressin, angiotensin-II, the phorbol ester TPA (12-O-tetradecanoylphorbol 13-acetate) and 8-bromo-cyclic AMP elicited a time- and dose-dependent increase in the labelling of the alpha-subunit of immunoprecipitated Gi2 which paralleled the loss of ability of low concentrations of the non-hydrolysable GTP analogue guanosine 5′-[beta gamma-imido]triphosphate (p[NH]ppG) to inhibit forskolin-stimulated adenylate cyclase activity (‘Gi’-function). The immunoprecipitation of phosphorylated Gi-2 alpha-subunit by the antiserum AS7 was blocked in a dose-dependent fashion by the inclusion of the C-terminal decapeptide of transducin, but not that of Gz (a ‘Gi-like’ G-protein which lacks the C-terminal cysteine group which is ADP-ribosylated by pertussis toxin in other members of the Gi family), in the immunoprecipitation assay. No labelling of the alpha-subunits of either Gi3 or Gs was observed. alpha-Gi2 was labelled in the basal state and this did not change over 15 min in the absence of ligand addition. In contrast to the monophasic dose-effect curves seen with vasopressin, angiotensin and TPA, the dose-effect curve for the glucagon-mediated increase in the labelling of alpha-Gi2 was markedly biphasic where the loss of Gi function paralleled the high-affinity component of the labelling of alpha-Gi2 caused by glucagon. TPA, TH-glucagon, angiotensin-II and vasopressin achieved similar maximal increases in the labelling of alpha-Gi2, which was approximately half that found after treatment of hepatocytes with either high glucagon concentrations (1 microM) or 8-bromocyclic AMP. Analysis of the phosphoamino acid content of immunoprecipitated alpha-Gi2 showed the presence of phosphoserine only. Incubation of hepatocyte membranes with [gamma-32P]ATP and purified protein kinase C, but not protein kinase A, led to the incorporation of label into immunoprecipitated alpha-Gi2. This labelling was abolished if membranes were obtained from cells which had received prior treatment with ligands shown to cause the phosphorylation of alpha-Gi2 in intact cells. We suggest that there are two possible sites for the phosphorylation of alpha-Gi2; one for C-kinase and the other for an unidentified kinase whose action is triggered by A-kinase activation.

scholarly journals Lifetime of muscarinic receptor–G-protein complexes determines coupling efficiency and G-protein subtype selectivity

2018 ◽  
Vol 115 (19) ◽  
pp. 5016-5021 ◽  
Author(s):  
Olga S. Ilyaskina ◽  
Horst Lemoine ◽  
Moritz Bünemann
Keyword(s):  
G Protein ◽  
G Proteins ◽  
Mammalian Cells ◽  
Protein Complexes ◽  
Coupling Efficiency ◽  
Dissociation Kinetics ◽  
Intact Cells ◽  
Permeabilized Cells ◽  
Subtype Selectivity ◽  
Intracellular Signals

G-protein–coupled receptors (GPCRs) are essential for the detection of extracellular stimuli by cells and transfer the encoded information via the activation of functionally distinct subsets of heterotrimeric G proteins into intracellular signals. Despite enormous achievements toward understanding GPCR structures, major aspects of the GPCR–G-protein selectivity mechanism remain unresolved. As this can be attributed to the lack of suitable and broadly applicable assays, we set out to develop a quantitative FRET-based assay to study kinetics and affinities of G protein binding to activated GPCRs in membranes of permeabilized cells in the absence of nucleotides. We measured the association and dissociation kinetics of agonist-induced binding of Gi/o, Gq/11, Gs, and G12/13 proteins to muscarinic M1, M2, and M3 receptors in the absence of nucleotides between fluorescently labeled G proteins and receptors expressed in mammalian cells. Our results show a strong quantitative correlation between not the on-rates of G-protein–M3–R interactions but rather the affinities of Gq and Go proteins to M3–Rs, their GPCR–G-protein lifetime and their coupling efficiencies determined in intact cells, suggesting that the G-protein subtype-specific affinity to the activated receptor in the absence of nucleotides is, in fact, a major determinant of the coupling efficiency. Our broadly applicable FRET-based assay represents a fast and reliable method to quantify the intrinsic affinity and relative coupling selectivity of GPCRs toward all G-protein subtypes.

Selective inactivation of guanine-nucleotide-binding regulatory protein (G-protein) α and βγ subunits by urea

2001 ◽  
Vol 354 (2) ◽  
pp. 337-344 ◽  
Author(s):  
William K. LIM ◽  
Richard R. NEUBIG
Keyword(s):  
G Protein ◽  
G Proteins ◽  
Regulatory Protein ◽  
Significant Loss ◽  
Membrane Extraction ◽  
Α Subunit ◽  
Mammalian Cell Lines ◽  
Membrane Bound ◽  
Guanine Nucleotide Binding ◽  
G Protein Coupled

G-protein-coupled receptors activate signal-transducing G-proteins, which consist of an α subunit and a βγ dimer. Membrane extraction with 5–7M urea has been used to uncouple receptors from endogenous G-proteins to permit reconstitution with purified G-proteins. We show that αi subunits are inactivated with 5M urea whereas the βγ dimer requires at least 7M urea for its inactivation. There is no significant loss of receptors. Surprisingly, Western-blot analysis indicates that the urea-denatured αi subunit remains mostly membrane-bound and that β is only partially removed. After 7M urea treatment, both αi1 and βγ subunits are required to restore high-affinity agonist binding and receptor-catalysed guanosine 5′-[γ-thio]triphosphate binding. We demonstrate the generality of this approach for four Gi-coupled receptors (α2A-adrenergic, adenosine A1, 5-hydroxytryptamine1A and µ-opioid) expressed in insect cells and two mammalian cell lines. Thus a selectivity of urea for G-protein α versus βγ subunits is established in both concentration and mechanism.

Muscarinic-induced mucin secretion and intracellular signaling by hamster tracheal goblet cells

1997 ◽  
Vol 272 (2) ◽  
pp. L230-L237 ◽  
Author(s):  
D. M. Steel ◽  
J. W. Hanrahan
Keyword(s):  
G Protein ◽  
Intracellular Signaling ◽  
Liquid Scintillation ◽  
Regulatory Protein ◽  
Calcium Ionophore ◽  
Goblet Cells ◽  
Acetoxymethyl Ester ◽  
Kinase C ◽  
Tracheal Epithelial ◽  
Guanine Nucleotide Binding

Hamster tracheal epithelial cell cultures were used to investigate muscarinic regulation of high-molecular-weight glycoconjugate (HMWG) secretion by airway goblet cells. HMWG were radiolabeled with N-acetyl-D-[1-(3)H]glucosamine, precipitated with trichloroacetic acid and phosphotungstic acid, and counted by liquid scintillation. Carbachol (100 microM) increased HMWG secretion (166.6 +/- 18.7%, P < 0.001, n = 20), and this response was blocked by the muscarinic receptor antagonist atropine. Ca2+ may not be essential for carbachol response since 1) carbachol-activated secretion was not inhibited by chelating extracellular Ca2+ with 1,2-bis(2-aminophenoxy)ethane-N,N,N',N'-tetraacetic acid (BAPTA) or by reducing both extracellular and intracellular Ca2+ with BAPTA-acetoxymethyl ester in low-Ca2+ medium; 2) the carbachol response was only partially blocked in low-Ca2+ medium; and 3) calcium ionophore did not stimulate HMWG secretion. However, carbachol-stimulated secretion was abolished by pertussis toxin (PTX), indicating the involvement of a PTX-sensitive guanine nucleotide-binding regulatory protein (G protein), and by the protein kinase C (PKC) inhibitor chelerythrine chloride. Furthermore, carbachol-stimulated secretion was not inhibited by overnight incubation with phorbol 12-myristate 13-acetate. In conclusion, carbachol-stimulated secretion of HMWG appears to be coupled to a PTX-sensitive G protein and requires the activation of a phorbol ester-insensitive PKC isoform.

scholarly journals Mechanisms in bradykinin stimulated arachidonate release and synthesis of prostaglandin and platelet activating factor

1992 ◽  
Vol 1 (2) ◽  
pp. 133-140 ◽  
Author(s):  
D. Ricupero ◽  
L. Taylor ◽  
A. Tlucko ◽  
J. Navarro ◽  
P. Polgar
Keyword(s):  
G Protein ◽  
Platelet Activating Factor ◽  
Calcium Ionophore ◽  
Calcium Ionophore A23187 ◽  
Ionophore A23187 ◽  
Down Regulation ◽  
Intact Cells ◽  
Tetradecanoyl Phorbol Acetate ◽  
Aluminium Fluoride ◽  
Arachidonate Release

Regulatory mechanisms in bradykinin (BK) activated release of arachidonate (ARA) and synthesis of prostaglandin (PG) and platelet activating factor (PAF) were studied in bovine pulmonary artery endothelial cells (BPAEC). A role for GTP binding protein (G-protein) in the binding of BK to the cells was determined. Guanosine 5-O- (thiotriphosphate), (GTPτS), lowered the binding affinity for BK and increased the Kd for the binding from 0.45 to 1.99 nM. The Bmax remained unaltered at 2.25 × 10-11mole. Exposure of the cells to aluminium fluoride also reduced the affinity for BK. Bradykinin-induced release of ARA proved pertussis toxin (PTX) sensitive, with a maximum sensitivity at 10 ug/ml PTX. GTPτS at 100 μM increased the release of arachidonate. The effect of GTPτS and BK was additive at suboptimal doses of BK up to 0.5 nM but never exceeded the levels of maximal BK stimulation at 50 nM. PTX also inhibited the release of ARA induced by the calcium ionophore, A23187. Phorbol 12-myristate 13-acetate or more commonly known as tetradecanoyl phorbol acetate (TPA) itself had little effect on release by the intact cells. However, at 100 nM it augmented the BK activated release. This was downregulated by overnight exposure to TPA and correlated with down-regulation of protein kinase C (PKC) activity. The down-regulation only affected the augmentation of ARA release by TPA but not the original BK activated release. TPA displayed a similar, but more potent amplification of PAF synthesis in response to both BK or the calcium ionophore A23187. These results taken together point to the participation of G-protein in the binding of BK to BPAEC and its activation of ARA release. Possibly two types of G-protein are involved, one associated with the receptor, the other activated by Ca2+and perhaps associated with phospholipase A2(PLA2). Our results further suggest that a separate route of activation, probably also PLA2related, takes place through a PKC catalysed phosphorylation.

Hereditary and acquired defects in signaling through the hormone-receptor-G protein complex

1994 ◽  
Vol 266 (2) ◽  
pp. F163-F174
Author(s):  
J. R. Raymond
Keyword(s):  
G Protein ◽  
Neutralizing Antibodies ◽  
Second Messengers ◽  
Regulatory Protein ◽  
Extracellular Signals ◽  
Extracellular Signaling ◽  
Genes Encoding ◽  
Membrane Bound ◽  
Guanine Nucleotide Binding ◽  
Signaling Components

Extracellular signals reach the interior of cells as second messengers through intermediary transducers located within or closely associated with the plasma membrane. One of the most common pathways involves the interaction of the extracellular signaling element with a membrane-bound receptor and guanine nucleotide-binding regulatory protein (G protein). Inherited and acquired defects that alter the function of the first messenger (hormone, neurotransmitter, autacoid, or paracrine substance) or either of the transducing components (G protein-coupled receptor or G protein) can lead to defective signaling and, ultimately, disease. Clinically relevant examples of defects of all three of those signaling components have recently been described. These can take the form of inherited or sporadic mutations of the genes encoding the various signaling components, or of neutralizing antibodies against those components. The purpose of this review is to summarize how acquired or inherited defects in each of those pathways might lead to diseases.

Sign in / Sign up

Export Citation Format

Share Document